Several new studies have demonstrated that small doses of gemcitabine combined with cisplatin can not only cause immunogenic death of lung cancer tumor cells but can also directly activate NK cells and increase IFN-γ secretion, thus inhibiting tumor growth. Here, IFNG is linked to neoplasm.